Peter D. Kies
2023
In 2023, Peter D. Kies earned a total compensation of $1.2M as Chief Financial Officer at Inovio Pharmaceuticals, a 28% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $172,314 |
|---|---|
| Option Awards | $218,593 |
| Salary | $622,881 |
| Stock Awards | $132,252 |
| Other | $15,000 |
| Total | $1,161,040 |
Kies received $622.9K in salary, accounting for 54% of the total pay in 2023.
Kies also received $172.3K in non-equity incentive plan, $218.6K in option awards, $132.3K in stock awards and $15K in other compensation.
Rankings
In 2023, Peter D. Kies' compensation ranked 942nd out of 2,238 executives tracked by ExecPay. In other words, Kies earned more than 57.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 942 out of 2,238 | 58th |
Division Manufacturing | 555 out of 1,216 | 54th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 68 out of 188 | 64th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 41 out of 125 | 67th |
Industry Surgical and Medical Instruments and Apparatus | 38 out of 105 | 64th |
Source: SEC filing on April 11, 2024.
Kies' colleagues
We found two more compensation records of executives who worked with Peter D. Kies at Inovio Pharmaceuticals in 2023.
News
Inovio Pharmaceuticals CEO Jacqueline Shea's 2023 pay falls 31% to $2.4M
April 11, 2024
Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
March 28, 2023
Inovio Pharmaceuticals CEO J Kim's 2021 pay jumps 32% to $6.2M
March 25, 2022
Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
March 25, 2021
Inovio Pharmaceuticals CEO J Kim's 2018 pay falls 30% to $3.1M
March 25, 2019